Laboratory Corporation of America Statistics
Share Statistics
Laboratory Corporation of America has 83.64M shares outstanding. The number of shares has increased by -5.23% in one year.
Shares Outstanding | 83.64M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | -0.39% |
Owned by Institutions (%) | n/a |
Shares Floating | 83.35M |
Failed to Deliver (FTD) Shares | 696 |
FTD / Avg. Volume | 0.12% |
Short Selling Information
The latest short interest is 2.03M, so 2.43% of the outstanding shares have been sold short.
Short Interest | 2.03M |
Short % of Shares Out | 2.43% |
Short % of Float | 2.44% |
Short Ratio (days to cover) | 3.53 |
Valuation Ratios
The PE ratio is 47.36 and the forward PE ratio is 15.25. Laboratory Corporation of America's PEG ratio is 0.24.
PE Ratio | 47.36 |
Forward PE | 15.25 |
PS Ratio | 1.63 |
Forward PS | 1.4 |
PB Ratio | 2.51 |
P/FCF Ratio | 22.65 |
PEG Ratio | 0.24 |
Enterprise Valuation
Laboratory Corporation of America has an Enterprise Value (EV) of 25.21B.
EV / Earnings | 60.32 |
EV / Sales | 2.07 |
EV / EBITDA | 18.74 |
EV / EBIT | 34.75 |
EV / FCF | 28.85 |
Financial Position
The company has a current ratio of 1.17, with a Debt / Equity ratio of 0.66.
Current Ratio | 1.17 |
Quick Ratio | 1.02 |
Debt / Equity | 0.66 |
Total Debt / Capitalization | 39.89 |
Cash Flow / Debt | 0.25 |
Interest Coverage | 3.64 |
Financial Efficiency
Return on equity (ROE) is 0.05% and return on capital (ROIC) is 3.5%.
Return on Equity (ROE) | 0.05% |
Return on Assets (ROA) | 0.02% |
Return on Capital (ROIC) | 3.5% |
Revenue Per Employee | 181.52K |
Profits Per Employee | 6.24K |
Employee Count | 67.00K |
Asset Turnover | 0.73 |
Inventory Turnover | 18.53 |
Taxes
Income Tax | 188.50M |
Effective Tax Rate | 0.33 |
Stock Price Statistics
The stock price has increased by 5.9% in the last 52 weeks. The beta is 1.04, so Laboratory Corporation of America's price volatility has been higher than the market average.
Beta | 1.04 |
52-Week Price Change | 5.9% |
50-Day Moving Average | 229.84 |
200-Day Moving Average | 216.6 |
Relative Strength Index (RSI) | 44.97 |
Average Volume (20 Days) | 594.33K |
Income Statement
In the last 12 months, Laboratory Corporation of America had revenue of $12.16B and earned $418.00M in profits. Earnings per share was $4.8.
Revenue | 12.16B |
Gross Profit | 3.36B |
Operating Income | 725.60M |
Net Income | 418.00M |
EBITDA | 1.35B |
EBIT | 725.60M |
Earnings Per Share (EPS) | 4.8 |
Balance Sheet
The company has $536.80M in cash and $5.95B in debt, giving a net cash position of -$5.42B.
Cash & Cash Equivalents | 536.80M |
Total Debt | 5.95B |
Net Cash | -5.42B |
Retained Earnings | 7.89B |
Total Assets | 18.61B |
Working Capital | 1.50B |
Cash Flow
In the last 12 months, operating cash flow was $1.33B and capital expenditures -$453.60M, giving a free cash flow of $874.10M.
Operating Cash Flow | 1.33B |
Capital Expenditures | -453.60M |
Free Cash Flow | 874.10M |
FCF Per Share | 10.04 |
Margins
Gross margin is 27.67%, with operating and profit margins of 5.97% and 3.44%.
Gross Margin | 27.67% |
Operating Margin | 5.97% |
Pretax Margin | 4.68% |
Profit Margin | 3.44% |
EBITDA Margin | 11.07% |
EBIT Margin | 5.97% |
FCF Margin | 7.19% |
Dividends & Yields
LH pays an annual dividend of $2.88, which amounts to a dividend yield of 1.24%.
Dividend Per Share | $2.88 |
Dividend Yield | 1.24% |
Dividend Growth (YoY) | 0% |
Payout Ratio | 54.55% |
Earnings Yield | 2.06% |
FCF Yield | 4.5% |
Analyst Forecast
The average price target for LH is $249, which is 7.1% higher than the current price. The consensus rating is "Buy".
Price Target | $249 |
Price Target Difference | 7.1% |
Analyst Consensus | Buy |
Analyst Count | 17 |
Stock Splits
The last stock split was on Jul 3, 2023. It was a forward split with a ratio of 291:250.
Last Split Date | Jul 3, 2023 |
Split Type | forward |
Split Ratio | 291:250 |
Scores
Altman Z-Score | 2.66 |
Piotroski F-Score | 7 |